RYAN SHANNON: Open Payments
NPI 1194322271 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,492 in 176 payments from 27 companies in 2025. Trend: 2023 $18,642 · 2024 $22,651 · 2025 $11,492
Speaker / faculty: $4,200Food & beverage: $2,824Consulting: $2,306Travel & lodging: $2,163
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 27 | $6,756 |
| GENZYME CORPORATION | 7 | $1,547 |
| UCB, Inc. | 4 | $998 |
| Biogen, Inc. | 15 | $241 |
| Amgen Inc. | 16 | $201 |
| TG Therapeutics, Inc. | 9 | $178 |
| Mallinckrodt Hospital Products Inc. | 7 | $163 |
| ARGENX US, INC. | 9 | $158 |
| Cycle Pharmaceuticals Inc | 12 | $145 |
| Axsome Therapeutics, Inc. | 10 | $141 |
Products named: Mavenclad, TYSABRI, UPLIZNA, BRIUMVI, ACTHAR, VYVGART HYTRULO, Symbravo, ZEPOSIA.
Industry payments across AL — which companies pay providers there.
